Aktiespot

Tactile Systems Technology, Inc. (Tactile Systems Technology, Inc) Aktie

TCMD

After-hours
$23.98-0.63 (-2.56%)
Post-Market:$23.980.00 (0.00%)
Chart wird geladen...
Tactile Systems Technology, Inc Logo

Tactile Systems Technology, Inc

Eröffnung24.33
Hoch24.61
Tief23.78
Volumen278.71k
P/E27.56
Marktkapitalisierung540.9M
52-Wochen-Hoch37.77
52-Wochen-Tief9.41
Durchschn. Volumen304.08k
DividendeN/A
Beta0.82
EPS0.87

Über Tactile Systems Technology, Inc. (Tactile Systems Technology, Inc) Aktie

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Unternehmensinformationen

Börse: NasdaqGM (NGM)
Sektor: Sundhed
Branche: Medicinsk udstyr
Adresse:
3701 Wayzata Boulevard
55416 Minneapolis, United States
Telefon: + 612 355 5100

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Anbefaling:1.20 - Stærk køb
Niedrigstes Kursziel
36.00
50.1%
Durchschnittliches Kursziel
39.50
64.7%
Median Kursziel
40.00
66.8%
Höchstes Kursziel
42.00
75.1%

Andere sehen auch: